CORD-19:0036b28fddf7e93da0970303672934ea2f9944e7 / 192912-193089 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1561","span":{"begin":0,"end":177},"obj":"Sentence"},{"id":"T48356","span":{"begin":0,"end":177},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, whether the combination therapy of ARBs with current CHF treatments has clinically incremental benefits, is unknown in dogs with myxomatous mitral valve disease (MMVD)."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T343","span":{"begin":149,"end":161},"obj":"Body_part"},{"id":"T344","span":{"begin":156,"end":161},"obj":"Body_part"}],"attributes":[{"id":"A343","pred":"uberon_id","subj":"T343","obj":"http://purl.obolibrary.org/obo/UBERON_0002135"},{"id":"A344","pred":"uberon_id","subj":"T344","obj":"http://purl.obolibrary.org/obo/UBERON_0003978"}],"text":"However, whether the combination therapy of ARBs with current CHF treatments has clinically incremental benefits, is unknown in dogs with myxomatous mitral valve disease (MMVD)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T773","span":{"begin":62,"end":65},"obj":"Disease"},{"id":"T774","span":{"begin":149,"end":169},"obj":"Disease"},{"id":"T775","span":{"begin":171,"end":175},"obj":"Disease"},{"id":"T51233","span":{"begin":62,"end":65},"obj":"Disease"},{"id":"T24509","span":{"begin":149,"end":169},"obj":"Disease"},{"id":"T70698","span":{"begin":171,"end":175},"obj":"Disease"}],"attributes":[{"id":"A773","pred":"mondo_id","subj":"T773","obj":"http://purl.obolibrary.org/obo/MONDO_0005009"},{"id":"A774","pred":"mondo_id","subj":"T774","obj":"http://purl.obolibrary.org/obo/MONDO_0003767"},{"id":"A775","pred":"mondo_id","subj":"T775","obj":"http://purl.obolibrary.org/obo/MONDO_0003767"},{"id":"A21502","pred":"mondo_id","subj":"T51233","obj":"http://purl.obolibrary.org/obo/MONDO_0005009"},{"id":"A59874","pred":"mondo_id","subj":"T24509","obj":"http://purl.obolibrary.org/obo/MONDO_0003767"},{"id":"A3802","pred":"mondo_id","subj":"T70698","obj":"http://purl.obolibrary.org/obo/MONDO_0003767"}],"text":"However, whether the combination therapy of ARBs with current CHF treatments has clinically incremental benefits, is unknown in dogs with myxomatous mitral valve disease (MMVD)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T528","span":{"begin":62,"end":65},"obj":"Phenotype"}],"attributes":[{"id":"A528","pred":"hp_id","subj":"T528","obj":"http://purl.obolibrary.org/obo/HP_0001635"}],"text":"However, whether the combination therapy of ARBs with current CHF treatments has clinically incremental benefits, is unknown in dogs with myxomatous mitral valve disease (MMVD)."}